In order to investigate how loci modifying smoking behavior influence circulating cotinine levels and lung cancer risk, we conducted an analysis within a nested lung cancer case-control study from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Circulating cotinine level measured in serum or plasma was included as a proxy of pre-diagnosis smoking behavior, together with traditional questionnaire-based smoking measures.
